Molgramostim topical gel - GeneScience

Drug Profile

Molgramostim topical gel - GeneScience

Alternative Names: Genfulin; GenLei; Topical hGM-CSF; Topical rhGM-CSF

Latest Information Update: 13 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GeneScience Pharmaceuticals
  • Class Chemoprotectants; Granulocyte-macrophage colony-stimulating factors; Recombinant proteins
  • Mechanism of Action Granulocyte macrophage colony stimulating factor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Burns; Wounds

Most Recent Events

  • 03 May 2017 GeneScience Pharmaceuticals and Shanghai Ninth People 's Hospital plan a clinical trial for Wounds (Intrauterine adhesions) in China (ChiCTR-IPR-17011242)
  • 13 Nov 2009 Molgramostim topical gel is still in preregistration for Wounds in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top